We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Cidara will get $27 million upfront as part of the deal with Johnson & Johnson and is eligible for up to $753 million in additional payments. Read More
Under the expanded deal, Catalent is dedicating a new high-speed filling line at its Bloomington site to vaccine production starting next month. Read More
Novartis has entered into a licensing and development agreement with Cambridge, UK-based Artios Pharma to develop new precision oncology drugs. Read More
Moderna has expanded its existing agreement with Catalent to boost COVID-19 vaccine production at Catalent’s fill-and-finish facility in Bloomington, Ind., to supply the U.S. market. Read More
The U.S. government has stepped in to address a serious manufacturing error at Emergent BioSolutions’ Baltimore, Md., facility that wasted 15 million Johnson & Johnson (J&J) vaccine doses. However, putting J&J in charge of the site and barring production of AstraZeneca (AZ)’s vaccine there isn’t likely to halt AZ’s production schedule, a White House official said Monday. Read More
Amgen is acquiring Seattle, Wash.-based Rodeo Therapeutics in a move to broaden its reach in regenerative medicine, in a deal worth up to $721 million. Read More
Novavax has enlisted GlaxoSmithKline (GSK) to help it mass produce its promising COVID-19 vaccine in the UK as the inoculation draws closer to potential authorization. Read More
A group of House Democrats has called on the Federal Trade Commission (FTC) to begin an investigation into potential collusion between insulin makers Eli Lilly, Novo Nordisk and Sanofi to significantly raise the price of the lifesaving drug. Read More